2022
DOI: 10.3390/biom12081163
| |Summarize |Cite
|
Sign up to set email alerts

N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism

Abstract: Similar to canine inflammatory enteropathy, inflammatory bowel disease (IBD) is a chronic idiopathic condition characterized by remission periods and recurrent flares in which diarrhea, visceral pain, rectal bleeding/bloody stools, and weight loss are the main clinical symptoms. Intestinal barrier function alterations often persist in the remission phase of the disease without ongoing inflammatory processes. However, current therapies include mainly anti-inflammatory compounds that fail to promote functional s… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
18
7
6
2

Citation Types

2
25
0
0

Year Published

Range
2022
2022
2026
2026

Publication Types

Select...
24
1
1

Relationship

1
25

Authors

Journals

Cited by 26 publications

(27 citation statements)

References 52 publications

2
25
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…The data further reveal that in our experimental conditions mPGA effect is independent from the glucosamine (monosaccharide portion of PGA), since glucosamine alone showed no beneficial effect in any of the studied parameters. In line with previous findings (Palenca et al, 2022), the effects of mPGA are mediated through agonism at the PPARα receptors. This is underscored by the nearly complete abolition of mPEA protective effects in our carcinogenesis model upon co‐administration of MK866.…”
Section: Discussion
supporting
confidence: 93%